GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals to announce Q2 FY27 results on Nov 4, 2026

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 28 Oct 2026, 03:27 PM IST  ·  BSE ID: 7282cc75-6235-4211-bb8c-f43a80e779ec
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet to discuss and approve its latest financial performance reports for the past quarter and six months.
🤖 AI Summary
  • Alembic Pharmaceuticals board to meet November 4, 2026.
  • Consider and approve unaudited financial results for Q2 FY27.
  • Also review results for the half-year ended September 30, 2026.
  • Trading window to reopen 48 hours post-results announcement.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders. Investors should await the financial results announcement.
👤
Who Is Affected
All shareholders of Alembic Pharmaceuticals Limited are affected as they will receive updated financial performance information.
🔍
Management Signal
The scheduled board meeting signals management's adherence to regulatory timelines for financial reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Alembic Pharmaceuticals Q2 FY27 results release.
Trading window re-opening announcement.
Review of Q2 FY27 financial performance metrics.
LOW RISK This is a standard procedural announcement of a board meeting for financial results. No inherent risks are present.
💡 Investor Takeaway
Alembic Pharmaceuticals will announce its unaudited financial results for the quarter and half-year ended September 30, 2026, on November 4, 2026. The trading window will reopen 48 hours later.
❓ Frequently Asked Questions
When will Alembic Pharmaceuticals announce its financial results?
Alembic Pharmaceuticals will announce its unaudited financial results for the quarter and half-year ended September 30, 2026, on November 4, 2026.
What is the purpose of the board meeting on November 4, 2026?
The board meeting of Alembic Pharmaceuticals on November 4, 2026, is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
When will the trading window reopen for Alembic Pharmaceuticals?
The trading window for dealing in securities of Alembic Pharmaceuticals will re-open 48 hours after the declaration of the financial results.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.